表紙
市場調査レポート

米国・ドイツ・スペインのポイントオブケア(POC)向けPT・APPT検査市場の分析:開業医/グループ検診、緊急治療室、外来治療センター、手術室、産院などの部門での詳細動向

2016 POC/Point-of-Care PT and APTT Testing Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

発行 Venture Planning Group 商品コード 269650
出版日 ページ情報 英文 366 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。

Local License: 同一事業所内

Back to Top
米国・ドイツ・スペインのポイントオブケア(POC)向けPT・APPT検査市場の分析:開業医/グループ検診、緊急治療室、外来治療センター、手術室、産院などの部門での詳細動向 2016 POC/Point-of-Care PT and APTT Testing Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
出版日: ページ情報: 英文 366 Pages
概要

当レポートでは、米国・ドイツ・スペインの3ヶ国における、ポイントオブケア(POC)向けのPT(プロトロンビン時間)およびAPPT(活性化部分トロンボプラスチン時間)の検査関連市場について分析し、市場全体および部門別(開業医/グループ検診、緊急治療室、外来治療センター、手術室、産院など)の今後の市場動向や傾向、規制・技術の動向、既存・新規製品の市場機会、競争構造、今後の市場機会と課題、各企業のプロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

エグゼクティブ・サマリー

分散型検査の合理的根拠

  • 概要
  • 規制動向
  • 経済動向
  • 人口動向
  • 技術動向
  • 社会動向
  • 治療の品質
  • 防衛的医療
  • 品質管理(QC)の問題点

世界の市場・技術の概要

  • イントロダクション
  • APTT(活性化部分トロンボプラスチン時間)
  • プロトロンビン時間(PT)
  • 検査装置:血液凝固分析器(全12社分)

現在・将来の技術

  • モノクローナル抗体
  • 免疫学的検定
  • ドライケミストリー
  • バイオセンサー
  • IT・オートメーション
  • 分子診断

米国市場

  • 市場概要
  • 開業医/グループ診療
  • 補助的医療施設
  • がんクリニック
  • 外来治療センター
  • 手術センター
  • 介護施設(ナーシングホーム)
  • 産院
  • 主要サプライヤーの装置設置台数・設置ベース・試薬販売額・市場シェア

ドイツ市場

  • 市場概要
  • 市場構造
  • 市場のサマリー
  • 検査件数・販売額の予測
  • 主要サプライヤーの装置設置台数・設置ベース・試薬販売額・市場シェア

スペイン市場

  • 市場概要
  • 市場構造
  • 市場のサマリー
  • 検査件数・販売額の予測
  • 主要サプライヤーの装置設置台数・設置ベース・試薬販売額・市場シェア

製品開発の主な機会

  • 定期/特殊化学検査
  • 細菌/感染症検査
  • 血液検査・フローサイトメトリー
  • 凝固検査

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者の主な種類
    • 市場の細分化

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

企業プロファイル(全49社)

  • Abbott
  • ADI/America Diagnostica
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Biomerieux
  • Bio-Rad
  • Biosite/Inverness/Alere
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • 栄研化学
  • EKF Diagnostics
  • 富士レビオ/Innogenetics
  • Helena Laboratories
  • Hologic/Gen-Probe
  • 堀場製作所
  • Instrumentation Laboratory
  • International Technidyne/Nexus DX
  • Kreatech
  • 協和メデックス
  • Life Technologies
  • Lonza
  • Mackay Life Sciences
  • Matritech
  • 日本光電
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • シスメックス
  • タカラバイオ
  • ThermoFisher
  • 東ソー
  • 和光純薬工業
  • Zycare/Alere

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCO20723

This new 366-page report from VPGMarketResearch contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
 
Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for coagulation procedures
  by market segment:
- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of coagulation procedures performed in POC testing locations.
- Review of leading coagulation analyzers, both currently marketed and
  those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation
   testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new coagulation instruments and reagent systems with potentially
  significant market appeal during the next five years.

- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 366 pages and 39 tables

Table of Contents

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Worldwide Market and Technology Overview

  • 1. Introduction
  • 2. Activated Partial Thromboplastin Time (APTT)
  • 3. Prothrombin Time (PT)
  • Instrumentation: Coagulation Analyzers Manufactured by:
    • Behnk Elektronik
    • Bio/Data
    • Cardiovascular Diagnostics
    • Diagnostica Stago
    • Helena Laboratories
    • Instrumentation Laboratory
    • ITC Hemochron
    • Roche
    • Siemens
    • Sysmex
    • Teco Medical Instruments
    • Trinity Biotech

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • c. Fluorescent Immunoassays
      • Fluorescent Polarization
      • Time-Resolved Pulse Fluorescence
    • d. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

U.S.A.

  • A. Market Overview
    • 1. Business Environment
      • a. Health Care Expenditures
      • b. Cost Consciousness
      • c. Reimbursement
      • d. Industry Consolidation
      • e. Managed Care
        • PPO
        • HMO
      • f. Hospitals
      • g. Admissions
      • h. Length of Stay
      • i. Industry Diversification
      • j. Physician Demographics
      • k. Aging Population
        • More Chronic Illness
        • Disease Incidence
        • Susceptibility to latrogenesis
        • Multiple Illnesses Cases
      • l. Laboratory Regulations
    • 2. Market Structure
      • a. Hospitals
      • b. Commercial/Private Laboratories
  • B. Physician Offices/Group Practices
    • 1. Market Summary
    • 2. Market Structure
    • 3. Test Volume and Sales Forecasts
  • C. Ancillary Hospital Locations
    • 1. Introduction
      • a. Emergency Departments
      • b. Operating Suites
      • c. Intensive Care Units
    • 2. Emergency Departments
      • a. Market Summary
      • b. Test volume and Sales Forecasts
    • 3. Operating and Recovery Suites
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
    • 4. ICUs/CCUs
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
  • D. Cancer Clinics
    • 1. Introduction
    • 2. Market Summary
    • 3. Test Volume and Sales Forecasts
  • E. Ambulatory Care Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • F. Surgery Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • G. Nursing Homes
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • H. Birth Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • I. Major Suppliers' Instrument Placements, Installed Base, Consumables Sales and Market Shares

Germany

  • A. Market Overview
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Instrument Placements, Installed Base, Consumables Sales and Market Shares

Spain

  • A. Business Environment
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Instrument Placements, Installed Base, Consumables Sales and Market Shares

Major Product Development Opportunities

  • A. Routine and Special Chemistry
  • B. Microbiology/Infectious Diseases
  • C. Hematology and Flow Cytometry
  • D. Coagulation

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott
  • ADI/America Diagnostica
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Biomerieux
  • Bio-Rad
  • Biosite/Inverness/Alere
  • Cephid
  • Chrono-Log
  • Corgenix
  • Decode
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio/Innogenetics
  • Helena Laboratories
  • Hologic/Gen-Probe
  • Horiba
  • Instrumentation Laboratory
  • International Technidyne/Nexus DX
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Lonza
  • Mackay Life Sciences
  • Matritech
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • Sysmex
  • Takara Bio
  • ThermoFisher
  • Tosoh
  • Wako
  • Zycare/Alere

List of Tables

  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing PT Tests
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices PT and APTT Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments PT and APTT Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Hospital Operating and Recovery Suites PT and APTT Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Hospital ICUs/CCUs PT and APTT Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Cancer Clinics Major PT and APTT Test Volume Forecast
  • U.S.A., Cancer Clinics Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers PT and APTT Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers PT and APTT Test Volume Forecast
  • U.S.A., Surgery Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes PT and APTT Test Volume Forecast
  • U.S.A., Nursing Homes Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers PT and APTT Test Volume Forecast
  • U.S.A., Birth Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares
  • Germany, Laboratory Performing Diagnostic Tests by Market Segment
  • Germany, Physician Offices/Group Practices PT and APTT Test Volume Forecast
  • Germany, Physician Offices/Group Practices Coagulation Reagent and Instrument Sales Forecast
  • Germany, Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares
  • Spain, Laboratory Performing PT and APTT Tests by Market Segment
  • Spain, Ambulatory Care Centers PT and APTT Test Volume Forecast
  • Spain, Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
  • Spain, Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares
Back to Top